The short version
- Beth Dobbin has written to Prime Minister Andy Burnham requesting greater financial support for research into myalgic encephalomyelitis.
- The former Olympian argues that the current lack of treatment options forces severe patients into long-term dependency, increasing welfare costs.
- Government spending on ME research has been limited, with recent investments totaling millions but falling short of what advocates deem necessary.
Former British Olympic sprinter Beth Dobbin has formally requested that Prime Minister Andy Burnham increase government funding for research into myalgic encephalomyelitis. In a letter sent to the head of government, Dobbin highlighted the severe impact of the chronic illness on her life and argued that neglecting scientific inquiry into the condition ultimately increases the financial strain on the state’s welfare system.
Dobbin, who competed in the Tokyo Games five years ago, revealed recently that she has been diagnosed with ME. The disease is characterized by fluctuating symptoms including severe fatigue that does not improve with rest, pain, sleep disturbances, and cognitive difficulties. For Dobbin, the condition has become debilitating to the point where she spends twenty-two hours each day in bed. She described the experience as feeling days away from death, emphasizing the profound physical toll the illness takes on those affected.
The scope of ME in the United Kingdom remains difficult to quantify precisely. Estimates suggest that more than 400,000 people live with the condition, though some experts believe the true number could exceed one million. Severity varies widely among patients; while some are able to maintain employment or education, others require round-the-clock care and tube feeding. Approximately twenty-five percent of those diagnosed fall into the severe category, a group that Dobbin notes currently lacks dedicated provisions within the National Health Service.
In her correspondence with Burnham, Dobbin criticized the historical treatment of ME by policymakers and medical institutions. She stated that the illness has been neglected and often attributed to psychological factors for years. This approach has resulted in minimal government funding for research compared to other diseases. Consequently, there are no approved treatments available for patients. Those suffering from ME often rely on off-label medications to manage a wide array of symptoms, which can include nausea, headaches, and significant cognitive impairment.
The physical limitations imposed by ME are extreme. Simple stimuli such as bright lights or loud sounds can trigger a crash that lasts for days or even months. Dobbin has left her home only five times this year. Despite knowing that giving an interview could cause a brutal deterioration in her health, she agreed to speak with BBC Sport to raise awareness about the condition and its impact on patients.
Dobbin linked the lack of medical progress directly to economic concerns. She noted that the government has expressed a desire to reduce the welfare bill. However, she argued that ME is so debilitating that severe patients are violently unwell and unable to care for themselves, let alone work. By funding research into what she described as a spiralling illness, the government could help patients regain their lives and potentially reduce long-term dependency on state benefits.
Prime Minister Burnham assumed office in July with vows to curb the rising cost of welfare spending. Department for Work and Pensions figures indicate that benefit spending has increased significantly in recent years and is projected to reach £408.6 billion by 2030-31. Dobbin’s letter positions ME research not just as a health issue, but as a fiscal imperative. She suggested that investing in understanding and treating the disease is necessary to address the growing welfare burden.
Historical government investment in ME research has been relatively low. Between April 2019 and March 2024, the UK government invested approximately £6.5 million into studying the condition. Earlier this year, under the previous leadership of Sir Keir Starmer, an additional £4.75 million was announced for a world-first genomics study into ME. While these steps represent some progress, Dobbin’s appeal underscores the perception among patients that current funding levels remain insufficient to drive meaningful medical breakthroughs.
The debate over ME funding highlights broader tensions in health policy regarding chronic, poorly understood illnesses. Advocates argue that without adequate research, patients are left with nowhere to turn within the public healthcare system except private care, which is inaccessible to many. Dobbin’s intervention brings attention to the gap between political promises on welfare reduction and the practical realities of treating complex neurological conditions.
As the government considers its budgetary priorities, the letter from Dobbin serves as a direct challenge to address the medical neglect of ME patients. The outcome of this appeal may influence future allocations for health research and shape how the administration balances immediate fiscal constraints with long-term public health investments. The situation remains unresolved, with patients continuing to suffer from a condition that lacks effective treatment options.
Sources behind this briefing
Go to the original reporting
- BBC Sport↗Olympian Dobbin writes to Prime Minister over ME funding
